Bayer’s sevabertinib gets priority review for treatment of non-small cell lung cancer
Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) and granted...
Bayers
Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) and granted...
